Global Oncology API Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Oncology API market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oncology API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oncology API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Oncology API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Oncology API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Oncology API include Fresenius Kabi Oncology, Suanfarma, Sterling, Shivalik Rasayan, PROCOS SPA, PolyPeptide, Olon Group, Neopharma and Natco, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oncology API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Oncology API, also provides the sales of main regions and countries. Of the upcoming market potential for Oncology API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oncology API sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oncology API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oncology API sales, projected growth trends, production technology, application and end-user industry.

Oncology API Segment by Company

Fresenius Kabi Oncology
Suanfarma
Sterling
Shivalik Rasayan
PROCOS SPA
PolyPeptide
Olon Group
Neopharma
Natco
Kekule Pharma
Hetero
GLS Pharma
Glenmark Life Sciences
Eisai Pharmaceuticals
Dr. Reddy's
CordenPharma
Concord Biotech
Biocon
Bachem
Aspen API
Aenova
Oncology API Segment by Type

Alkylating Agents
Antimetabolites
Others
Oncology API Segment by Application

Immunotherapy
Chemotherapy
Targeted Therapy
Others
Oncology API Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncology API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oncology API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oncology API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Oncology API Market Size, 2020 VS 2024 VS 2031
1.3 Global Oncology API Market Size Estimates and Forecasts (2020-2031)
1.4 Global Oncology API Sales Estimates and Forecasts (2020-2031)
1.5 Global Oncology API Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Oncology API Market Dynamics
2.1 Oncology API Industry Trends
2.2 Oncology API Industry Drivers
2.3 Oncology API Industry Opportunities and Challenges
2.4 Oncology API Industry Restraints
3 Oncology API Market by Manufacturers
3.1 Global Oncology API Revenue by Manufacturers (2020-2025)
3.2 Global Oncology API Sales by Manufacturers (2020-2025)
3.3 Global Oncology API Average Sales Price by Manufacturers (2020-2025)
3.4 Global Oncology API Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Oncology API Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Oncology API Manufacturers, Product Type & Application
3.7 Global Oncology API Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Oncology API Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oncology API Players Market Share by Revenue in 2024
3.8.3 2024 Oncology API Tier 1, Tier 2, and Tier 3
4 Oncology API Market by Type
4.1 Oncology API Type Introduction
4.1.1 Alkylating Agents
4.1.2 Antimetabolites
4.1.3 Others
4.2 Global Oncology API Sales by Type
4.2.1 Global Oncology API Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Oncology API Sales by Type (2020-2031)
4.2.3 Global Oncology API Sales Market Share by Type (2020-2031)
4.3 Global Oncology API Revenue by Type
4.3.1 Global Oncology API Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Oncology API Revenue by Type (2020-2031)
4.3.3 Global Oncology API Revenue Market Share by Type (2020-2031)
5 Oncology API Market by Application
5.1 Oncology API Application Introduction
5.1.1 Immunotherapy
5.1.2 Chemotherapy
5.1.3 Targeted Therapy
5.1.4 Others
5.2 Global Oncology API Sales by Application
5.2.1 Global Oncology API Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Oncology API Sales by Application (2020-2031)
5.2.3 Global Oncology API Sales Market Share by Application (2020-2031)
5.3 Global Oncology API Revenue by Application
5.3.1 Global Oncology API Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Oncology API Revenue by Application (2020-2031)
5.3.3 Global Oncology API Revenue Market Share by Application (2020-2031)
6 Global Oncology API Sales by Region
6.1 Global Oncology API Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Oncology API Sales by Region (2020-2031)
6.2.1 Global Oncology API Sales by Region (2020-2025)
6.2.2 Global Oncology API Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Oncology API Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Oncology API Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Oncology API Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Oncology API Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Oncology API Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Oncology API Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Oncology API Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Oncology API Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Oncology API Revenue by Region
7.1 Global Oncology API Revenue by Region
7.1.1 Global Oncology API Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Oncology API Revenue by Region (2020-2025)
7.1.3 Global Oncology API Revenue by Region (2026-2031)
7.1.4 Global Oncology API Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Oncology API Revenue (2020-2031)
7.2.2 North America Oncology API Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Oncology API Revenue (2020-2031)
7.3.2 Europe Oncology API Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Oncology API Revenue (2020-2031)
7.4.2 Asia-Pacific Oncology API Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Oncology API Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Oncology API Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Fresenius Kabi Oncology
8.1.1 Fresenius Kabi Oncology Comapny Information
8.1.2 Fresenius Kabi Oncology Business Overview
8.1.3 Fresenius Kabi Oncology Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Fresenius Kabi Oncology Oncology API Product Portfolio
8.1.5 Fresenius Kabi Oncology Recent Developments
8.2 Suanfarma
8.2.1 Suanfarma Comapny Information
8.2.2 Suanfarma Business Overview
8.2.3 Suanfarma Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Suanfarma Oncology API Product Portfolio
8.2.5 Suanfarma Recent Developments
8.3 Sterling
8.3.1 Sterling Comapny Information
8.3.2 Sterling Business Overview
8.3.3 Sterling Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Sterling Oncology API Product Portfolio
8.3.5 Sterling Recent Developments
8.4 Shivalik Rasayan
8.4.1 Shivalik Rasayan Comapny Information
8.4.2 Shivalik Rasayan Business Overview
8.4.3 Shivalik Rasayan Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Shivalik Rasayan Oncology API Product Portfolio
8.4.5 Shivalik Rasayan Recent Developments
8.5 PROCOS SPA
8.5.1 PROCOS SPA Comapny Information
8.5.2 PROCOS SPA Business Overview
8.5.3 PROCOS SPA Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 PROCOS SPA Oncology API Product Portfolio
8.5.5 PROCOS SPA Recent Developments
8.6 PolyPeptide
8.6.1 PolyPeptide Comapny Information
8.6.2 PolyPeptide Business Overview
8.6.3 PolyPeptide Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 PolyPeptide Oncology API Product Portfolio
8.6.5 PolyPeptide Recent Developments
8.7 Olon Group
8.7.1 Olon Group Comapny Information
8.7.2 Olon Group Business Overview
8.7.3 Olon Group Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Olon Group Oncology API Product Portfolio
8.7.5 Olon Group Recent Developments
8.8 Neopharma
8.8.1 Neopharma Comapny Information
8.8.2 Neopharma Business Overview
8.8.3 Neopharma Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Neopharma Oncology API Product Portfolio
8.8.5 Neopharma Recent Developments
8.9 Natco
8.9.1 Natco Comapny Information
8.9.2 Natco Business Overview
8.9.3 Natco Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Natco Oncology API Product Portfolio
8.9.5 Natco Recent Developments
8.10 Kekule Pharma
8.10.1 Kekule Pharma Comapny Information
8.10.2 Kekule Pharma Business Overview
8.10.3 Kekule Pharma Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Kekule Pharma Oncology API Product Portfolio
8.10.5 Kekule Pharma Recent Developments
8.11 Hetero
8.11.1 Hetero Comapny Information
8.11.2 Hetero Business Overview
8.11.3 Hetero Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Hetero Oncology API Product Portfolio
8.11.5 Hetero Recent Developments
8.12 GLS Pharma
8.12.1 GLS Pharma Comapny Information
8.12.2 GLS Pharma Business Overview
8.12.3 GLS Pharma Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 GLS Pharma Oncology API Product Portfolio
8.12.5 GLS Pharma Recent Developments
8.13 Glenmark Life Sciences
8.13.1 Glenmark Life Sciences Comapny Information
8.13.2 Glenmark Life Sciences Business Overview
8.13.3 Glenmark Life Sciences Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Glenmark Life Sciences Oncology API Product Portfolio
8.13.5 Glenmark Life Sciences Recent Developments
8.14 Eisai Pharmaceuticals
8.14.1 Eisai Pharmaceuticals Comapny Information
8.14.2 Eisai Pharmaceuticals Business Overview
8.14.3 Eisai Pharmaceuticals Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Eisai Pharmaceuticals Oncology API Product Portfolio
8.14.5 Eisai Pharmaceuticals Recent Developments
8.15 Dr. Reddy's
8.15.1 Dr. Reddy's Comapny Information
8.15.2 Dr. Reddy's Business Overview
8.15.3 Dr. Reddy's Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Dr. Reddy's Oncology API Product Portfolio
8.15.5 Dr. Reddy's Recent Developments
8.16 CordenPharma
8.16.1 CordenPharma Comapny Information
8.16.2 CordenPharma Business Overview
8.16.3 CordenPharma Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 CordenPharma Oncology API Product Portfolio
8.16.5 CordenPharma Recent Developments
8.17 Concord Biotech
8.17.1 Concord Biotech Comapny Information
8.17.2 Concord Biotech Business Overview
8.17.3 Concord Biotech Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 Concord Biotech Oncology API Product Portfolio
8.17.5 Concord Biotech Recent Developments
8.18 Biocon
8.18.1 Biocon Comapny Information
8.18.2 Biocon Business Overview
8.18.3 Biocon Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.18.4 Biocon Oncology API Product Portfolio
8.18.5 Biocon Recent Developments
8.19 Bachem
8.19.1 Bachem Comapny Information
8.19.2 Bachem Business Overview
8.19.3 Bachem Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.19.4 Bachem Oncology API Product Portfolio
8.19.5 Bachem Recent Developments
8.20 Aspen API
8.20.1 Aspen API Comapny Information
8.20.2 Aspen API Business Overview
8.20.3 Aspen API Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.20.4 Aspen API Oncology API Product Portfolio
8.20.5 Aspen API Recent Developments
8.21 Aenova
8.21.1 Aenova Comapny Information
8.21.2 Aenova Business Overview
8.21.3 Aenova Oncology API Sales, Price, Revenue and Gross Margin (2020-2025)
8.21.4 Aenova Oncology API Product Portfolio
8.21.5 Aenova Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Oncology API Value Chain Analysis
9.1.1 Oncology API Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oncology API Production Mode & Process
9.2 Oncology API Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oncology API Distributors
9.2.3 Oncology API Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings